Literature DB >> 8742047

Oxidative stress after acute and chronic application of beta-amyloid fragment 25-35 in cortical cultures.

C Café1, C Torri, L Bertorelli, N Angeretti, E Lucca, G Forloni, F Marzatico.   

Abstract

The aim of this work was to investigate whether free radical reactions play a role in beta-amyloid neurotoxicity. Rat cortical neurons were exposed acutely (24 h) or chronically (3, 7 days) to beta-amyloid biologically active fragment beta 25-35 (50 microM). In these conditions, where only the longest exposure induced neuronal death, superoxide dismutase activity was increased after acute exposure but no change was detected after chronic treatments, whereas a different pattern was observed for glutathione peroxidase. In the basal condition, there was an eight-fold increase in dichlorofluoroscein, used as peroxide production marker, in neuronal cells after 7 days treatment with beta 25-35. Moreover, the intracellular peroxide production induced by Fe2+/ascorbate stimulation was amplified by beta 25-35, increasingly up to 7 days of exposure, by which time the dichlorofluoroscein-stimulated levels were 33 times higher than in controls. In conclusion, our results show that oxidative stress and free radical production are linked to beta 25-35 exposure and may contribute to neurodegenerative events associated with beta-amyloid deposits in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8742047     DOI: 10.1016/0304-3940(95)12250-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Transgene delivery with a cationic lipid in the presence of amyloid beta (betaAP) peptide.

Authors:  P S Ajmani; W Wang; F Tang; M A King; E M Meyer; J A Hughes
Journal:  Neurochem Res       Date:  2001-03       Impact factor: 3.996

Review 2.  The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration?

Authors:  D H Small
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

3.  Resistance to the apoptotic effect of aggregated amyloid-beta peptide in several different cell types including neuronal- and hepatoma-derived cell lines.

Authors:  M Mazziotti; D H Perlmutter
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

4.  Omega-3 fatty acid obtained from Nannochloropsis oceanica cultures grown under low urea protect against Abeta-induced neural damage.

Authors:  Ying-Jang Lai
Journal:  J Food Sci Technol       Date:  2014-04-23       Impact factor: 2.701

5.  The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor.

Authors:  J Meunier; J Ieni; T Maurice
Journal:  Br J Pharmacol       Date:  2006-10-23       Impact factor: 8.739

6.  Amyloid beta peptide impaired carbachol but not glutamate-mediated phosphoinositide pathways in cultured rat cortical neurons.

Authors:  H M Huang; H C Ou; S J Hsieh
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

7.  Amyloid beta-peptide (1-40)-mediated oxidative stress in cultured hippocampal neurons. Protein carbonyl formation, CK BB expression, and the level of Cu, Zn, and Mn SOD mRNA.

Authors:  M Y Aksenov; M V Aksenova; W R Markesbery; D A Butterfield
Journal:  J Mol Neurosci       Date:  1998-06       Impact factor: 3.444

8.  Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25-35) are dependent on stimulation-protocol and genetic background.

Authors:  Simon Gengler; Victor A Gault; Patrick Harriott; Christian Hölscher
Journal:  Exp Brain Res       Date:  2006-12-15       Impact factor: 2.064

9.  Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway.

Authors:  Jiunn-Tay Lee; Jan Xu; Jin-Moo Lee; Grace Ku; Xianlin Han; Ding-I Yang; Shawei Chen; Chung Y Hsu
Journal:  J Cell Biol       Date:  2004-01-05       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.